Exclusive

Publication

Byline

Singapore designs electronic skin combining sensing and visualisation in single device

Singapore, Sept. 29 -- Researchers from the National University of Singapore (NUS) have developed a next-generation electronic skin that can both sense and directly visualise pressure in real time, ad... Read More


Grunenthal partners with DKSH to bring four pain medicines to eight new markets in APAC

Singapore, Sept. 29 -- Grunenthal, a global leader in pain management and research, and DKSH Business Unit Healthcare, a strategic healthcare business partner and leading provider of Market Expansion ... Read More


Korea's Lunit expands AI-powered breast cancer screening across Stockholm Region

Singapore, Sept. 29 -- South Korea-based Lunit, a leading provider of AI for cancer diagnostics and precision oncology, has announced that its AI-powered mammography solution, Lunit INSIGHT MMG, will ... Read More


Singapore named GA4GH's Asia-Pacific anchor for global genomics

Singapore, Sept. 29 -- Singapore is hosting the Global Alliance for Genomics and Health (GA4GH) 14th Plenary meeting from 28 September to 2 October 2026 - the first time the flagship meeting has been ... Read More


New Digestive Health Centre opens at Woodlands Hospital in Singapore

Singapore, Sept. 28 -- A new Digestive Health Centre has opened at the Woodlands Hospital in Singapore. The Centre brings together comprehensive digestive health services and is supported by multidisc... Read More


China's InnoCare inks $3.5 B deal with Eli Lilly to develop new medicines

Singapore, Sept. 28 -- InnoCare Pharma, a China-based biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, has entered into a strategic research collaboration and lic... Read More


Japan Agency for Medical Research and Development provides Euro2.8 B grant to United Immunity

Singapore, Sept. 28 -- United Immunity, a clinical stage biotechnology company, has raised a total of Euro2.2 billion in private financing, comprising Euro1.8 billion through a third-party allotment o... Read More


European Commission grants marketing authorisation for NEZGLYAL, first pharmacological treatment for cALD

Singapore, Sept. 28 -- Neuraxpharm Group and Minoryx Therapeutics have announced that the European Commission has granted marketing authorisation under exceptional circumstances for NEZGLYAL(R) (lerig... Read More


Deep Origin deploys AI-powered ADMET models across drug discovery programmes

Singapore, Sept. 28 -- Deep Origin and partners in the Pharmacological Research and Evaluation through Digital Integration and Clinical Trials Simulation (PREDICTS) consortium announced that their new... Read More


APEC's Opportunity to Lead: Transforming Lung Cancer Outcomes Across Asia Pacific

Singapore, Sept. 28 -- As Asia Pacific economies grapple with ageing populations, shrinking workforces and rising healthcare expenditure, they are also at the center of the global fight against lung c... Read More